These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1269 related items for PubMed ID: 18486235

  • 1. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD, Wang CH, Shwarz M, Shults J.
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [Abstract] [Full Text] [Related]

  • 2. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD, Shults J.
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [Abstract] [Full Text] [Related]

  • 3. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
    Amsterdam JD, Lorenzo-Luaces L, Soeller I, Li SQ, Mao JJ, DeRubeis RJ.
    J Affect Disord; 2015 Oct 01; 185():31-7. PubMed ID: 26143402
    [Abstract] [Full Text] [Related]

  • 4. Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.
    Amsterdam JD, Wang G, Shults J.
    Acta Psychiatr Scand; 2010 Mar 01; 121(3):201-8. PubMed ID: 19694630
    [Abstract] [Full Text] [Related]

  • 5. Venlafaxine monotherapy in women with bipolar II and unipolar major depression.
    Amsterdam JD, Garcia-España F.
    J Affect Disord; 2000 Sep 01; 59(3):225-9. PubMed ID: 10854639
    [Abstract] [Full Text] [Related]

  • 6. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.
    Eur Neuropsychopharmacol; 2008 Jul 01; 18(7):535-49. PubMed ID: 18501566
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode.
    Amsterdam J.
    J Clin Psychopharmacol; 1998 Oct 01; 18(5):414-7. PubMed ID: 9790160
    [Abstract] [Full Text] [Related]

  • 8. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Oct 01; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness and mood conversion rate of short-term fluoxetine monotherapy in patients with rapid cycling bipolar II depression versus patients with nonrapid cycling bipolar II depression.
    Amsterdam JD, Luo L, Shults J.
    J Clin Psychopharmacol; 2013 Jun 01; 33(3):420-4. PubMed ID: 23609385
    [Abstract] [Full Text] [Related]

  • 10. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD, Shults J.
    J Affect Disord; 2009 May 01; 115(1-2):234-40. PubMed ID: 18694599
    [Abstract] [Full Text] [Related]

  • 11. Ziprasidone monotherapy in bipolar II depression: an open trial.
    Liebowitz MR, Salmán E, Mech A, Dunner D, Johnson AE, Akhtar J, Pratap R.
    J Affect Disord; 2009 Nov 01; 118(1-3):205-8. PubMed ID: 19264363
    [Abstract] [Full Text] [Related]

  • 12. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
    Keck PE, Orsulak PJ, Cutler AJ, Sanchez R, Torbeyns A, Marcus RN, McQuade RD, Carson WH, CN138-135 Study Group.
    J Affect Disord; 2009 Jan 01; 112(1-3):36-49. PubMed ID: 18835043
    [Abstract] [Full Text] [Related]

  • 13. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.
    J Affect Disord; 2008 Jan 01; 105(1-3):101-8. PubMed ID: 17531327
    [Abstract] [Full Text] [Related]

  • 14. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D.
    Clin Ther; 2011 Nov 01; 33(11):1643-58. PubMed ID: 22054797
    [Abstract] [Full Text] [Related]

  • 15. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):94-9. PubMed ID: 19007842
    [Abstract] [Full Text] [Related]

  • 16. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun 01; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 17. Predictors of remission in 208 drug-resistant depressive patients treated with electroconvulsive therapy.
    Medda P, Mauri M, Toni C, Mariani MG, Rizzato S, Miniati M, De Simone L, Perugi G.
    J ECT; 2014 Dec 01; 30(4):292-7. PubMed ID: 24625706
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.
    J Clin Psychiatry; 2001 Aug 01; 62(8):623-30. PubMed ID: 11561935
    [Abstract] [Full Text] [Related]

  • 19. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov 01; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 20. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    McElroy SL, Martens BE, Winstanley EL, Creech R, Malhotra S, Keck PE.
    J Affect Disord; 2010 Jul 01; 124(1-2):157-63. PubMed ID: 19963274
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 64.